| Identification | Back Directory | [Name]
AVN-101 | [CAS]
1061354-48-0 | [Synonyms]
AVN-101 HCl
1025725-91-0 (free)
AVN-101 1061354-48-0
2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride
1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-phenylethyl)-, hydrochloride (1:1) | [Molecular Formula]
C21H24N2*ClH | [MDL Number]
MFCD30738705 | [MOL File]
1061354-48-0.mol | [Molecular Weight]
340.9 |
| Hazard Information | Back Directory | [Uses]
AVN-101 hydrochloride is a potent, brain-penetrant and orally active 5-HT7 receptor antagonist (Ki of 153 pM), with slightly lesser potency toward 5-HT6, 5-HT2A, and 5HT-2C receptors (Ki values of 2.04 nM, 1.56 ?nM, and 1.17? nM, respectively). AVN-101 hydrochloride also exhibits a rather high affinity toward histamine H1 (Ki of 0.58 nM) and adrenergic α2A, α2B, and α2C (Ki= 0.41-3.6 nM) receptors. AVN-101 hydrochloride can be studied in such diseases as general anxiety disorders, depression, schizophrenia, and multiple sclerosis[1]. | [IC 50]
5-HT7 Receptor: 0.153 nM (Ki); 5-HT2C Receptor: 1.17 nM (Ki); 5-HT2A Receptor: 1.56 nM (Ki); 5-HT6 Receptor: 2.04 nM (Ki); 5-HT2B Receptor: 10.6 nM (Ki); 5-HT1A Receptor: 61 nM (Ki); 5-HT1B Receptor: 720 nM (Ki); H1 Receptor: 0.58 nM (Ki); Alpha-2B adrenergic receptor: 0.41 nM (Ki); Alpha-2A adrenergic receptor: 1.77 nM (Ki); Alpha-2C adrenergic receptor: 3.55 nM (Ki); Alpha-1B adrenergic receptor: 9.4 nM (Ki); Alpha-1A adrenergic receptor: 18.9 nM (Ki); Alpha-1D adrenergic receptor: 30.2 nM (Ki) | [References]
[1] Alexandre V Ivachtchenko, et al. AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders. J Alzheimers Dis. 2016 May 25;53(2):583-620. DOI:10.3233/JAD-151146 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|